Literature DB >> 20646793

Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin.

Xiangping Liu1, Yingxiang Du.   

Abstract

Duloxetine holds a special promise as an antidepressant, and its effect depends on its binding to human serum albumin (HSA). For this reason, the binding mechanism of duloxetine with HSA was investigated. The specific binding site in HSA was identified and binding constants were determined. Duloxetine could compete with dansyl-L-proline (DLP), a site II marker for binding to site II. Binding constants between duloxetine and HSA were 1.75x10(3) L mol(-1) and 3.74x10(3) L mol(-1) at pH 7.4 and pH 8.5, respectively. The interaction process of enantiomers and HSA was susceptible to pH change. It was concluded that specific binding position of duloxetine was located in site II, and the B conformation of HSA possibly excelled the N conformation in identifying and binding to enantiomers. 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646793     DOI: 10.1016/j.ejmech.2010.05.063

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Stereoselective binding of chiral drugs to plasma proteins.

Authors:  Qi Shen; Lu Wang; Hui Zhou; Hui-di Jiang; Lu-shan Yu; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2013-07-15       Impact factor: 6.150

2.  A structure-based model for predicting serum albumin binding.

Authors:  Katrina W Lexa; Elena Dolghih; Matthew P Jacobson
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

3.  Investigation of human albumin-induced circular dichroism in dansylglycine.

Authors:  Fernanda S Graciani; Valdecir F Ximenes
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.